Skip to main content

Table 7 Changes in process indicators°

From: Effectiveness of the introduction of a Chronic Care Model-based program for type 2 diabetes in Belgium

  % of patients receiving services Evolution 2003-2006
  2003 2006 P value for the Δ
in both regions *
P value for the Δ
between both regions**
HbA1c test     
   Intervention region 65.52 71.25 +5.73 (p < 0.0001) p = 0.0117 (1)
   Control region 68.58 70.60 +2.02 (p = 0.0580)  
Total Cholesterol test     
   Intervention region 72.53 73.33 +0.80 (p = 0.3888) p = 0.0190 (1)
   Control region 74.21 69.14 -2.59 (p = 0.0178)  
Statin therapy     
   Intervention region 27.07 45.15 +18.08 (p < 0.0001) p = 0.0002 (1)
   Control region 25.15 37.54 +12.39 (p < 0.0001)  
Micro-albuminuria test     
   Intervention region 20.57 25.96 +5.39 (p < 0.0001) p = 0.1325
   Control region 15.71 18.34 +2.63 (p = 0.0037)  
Influenza vaccination     
   Intervention region 57.43 58.14 +0.71 (p = 0.4627) p = 0.0462 (2)
   Control region 50.35 53.91 +3.56 (p = 0.0007)  
Ophthalmologist visit     
   Intervention region 34.72 36.10 +1.38 (p = 0.1360) p = 0.9300
   Control region 31.18 32.36 +1.18 (p = 0.2653)  
  1. °GEE model; Δ = evolution; *P value for the evolution (2003-2006) in the intervention and control region; **P value for the evolution (2003-2006) between the intervention and control region, (1) significantly greater change in the intervention region (2) significantly greater change in the control region